Energy Metabolism Probe Development Service
Energy metabolism is a core indicator of mitochondrial function, oxidative phosphorylation, glycolytic adaptation, metabolic stress, drug response, disease progression, and cell viability. MitoGlowing™ provides a comprehensive Energy Metabolism Probe Development Service, including NADH/NAD⁺ Ratio Probes Development Service, ATP/ADP Probes Development Service, and Metabolite Probes Development Service, to support mitochondrial energy metabolism analysis, drug screening, metabolic toxicity evaluation, cancer research, disease models, and translational metabolic profiling.
Introduction to Energy Metabolism Probes
Cellular energy metabolism depends on coordinated biochemical pathways, including glycolysis, the TCA cycle, oxidative phosphorylation, fatty acid oxidation, amino acid metabolism, nucleotide metabolism, and redox cofactor cycling. Mitochondria are central to these processes because they generate ATP, regulate NADH/NAD⁺ redox balance, maintain membrane potential, coordinate metabolite flux, and interact with ROS, calcium, apoptosis, and biosynthetic pathways.
Energy metabolism probes allow researchers to convert dynamic metabolic changes into measurable optical, luminescent, mass spectrometric, or biosensor-based signals. These probes and assays can monitor ATP/ADP ratio, NADH/NAD⁺ ratio, glucose utilization, fatty acid β-oxidation, lactate production, TCA cycle intermediates, metabolite flux, and pathway-specific metabolic activity.
Because metabolic pathways are highly dynamic and context-dependent, energy metabolism probe development requires careful optimization of target specificity, response kinetics, signal-to-background ratio, subcellular localization, live-cell compatibility, biological matrix tolerance, and quantitative analysis strategy. Depending on project needs, probes and assays can be designed for live-cell imaging, confocal microscopy, two-photon imaging, microplate detection, luminescence-based high-throughput screening, LC-MS/MS workflows, isotope tracing, organoid models, and selected preclinical research systems.
Our Services
NADH/NAD⁺ Ratio Probes Development Service
Development of fluorescent NADH probes, near-infrared NADH imaging tools, bioluminescent NAD/NADH assays, enzymatic cycling workflows, and high-throughput NAD⁺ metabolism screening systems.
- Mitochondrial respiration and redox status analysis
- Cancer metabolism and NAMPT inhibitor screening
- Mitochondrial disease and rare disease model research
- Skin metabolism, NAD⁺ precursor, supplement, and sports nutrition evaluation
ATP/ADP Probes Development Service
Development of ADP-selective luminescent probes, ATP/ADP ratiometric biosensors, genetically encoded reporters, live-cell imaging workflows, organoid models, and plate-reader-compatible assays.
- Live-cell ATP/ADP ratio imaging
- ADP-selective probe development
- Mitochondrial ATP production and energetic stress analysis
- Kidney organoid nephrotoxicity and high-content drug screening
Metabolite Probes Development Service
Development of fluorescent metabolite imaging probes, chemoselective labeling probes, LC-MS/MS derivatization reagents, stable isotope tracing workflows, TMT-compatible metabolomics probes, and high-throughput discovery platforms.
- Mitochondrial metabolite imaging
- Drug metabolite discovery and cancer metabolic profiling
- Fatty acid oxidation and glucose metabolism studies
- Microbiome-drug interaction and isotope tracing workflow development
Features of Energy Metabolism Probe Development
- Multi-analyte energy metabolism coverage for NADH/NAD⁺ ratio, ATP/ADP ratio, metabolite abundance, metabolic flux, mitochondrial membrane potential, glucose metabolism, lactate metabolism, fatty acid oxidation, and customized metabolite panels.
- Mitochondria-focused probe engineering with optimization of mitochondrial localization, membrane permeability, organelle retention, low cytotoxicity, and compatibility with mitochondrial function assays.
- Flexible detection strategies including fluorescence, near-infrared imaging, two-photon imaging, time-resolved luminescence, bioluminescence, enzymatic cycling, genetically encoded biosensors, LC-MS/MS labeling, and stable isotope tracing.
- Live-cell and real-time monitoring through probes and reporters suitable for dynamic metabolic imaging in live cells, organoids, tumor spheroids, tissue models, and selected preclinical research systems.
- High-throughput screening compatibility for 96-well, 384-well, low-volume 384-well, 1536-well, automated imaging, luminescence readers, fluorescence plate readers, and high-content screening workflows.
- Application-specific validation for drug metabolic toxicity, cancer metabolism, mitochondrial disease, neurodegeneration, cardiovascular models, metabolic disease, skin metabolism, supplement evaluation, and organoid-based safety testing.
Development Workflow
MitoGlowing™ provides an integrated energy metabolism probe development workflow covering project strategy, molecular probe design, biosensor or assay engineering, photophysical and biochemical characterization, biological validation, and application-specific workflow optimization.
Project Design & Metabolic Readout Strategy
- Define the target application, such as mitochondrial function analysis, drug metabolic toxicity evaluation, cancer metabolism research, high-throughput screening, metabolic disease modeling, or translational biomarker studies.
- Select the preferred metabolic readout, including NADH/NAD⁺ ratio, ATP/ADP ratio, metabolite abundance, metabolic flux, glucose uptake, fatty acid oxidation, or multi-parameter metabolic profiling.
- Determine the preferred detection platform, such as fluorescence imaging, luminescence assay, genetically encoded biosensor, LC-MS/MS, isotope tracing, plate-reader assay, high-content imaging, or organoid workflow.
- Design validation strategies using metabolic inhibitors, respiratory chain modulators, glycolysis inhibitors, ATP synthase inhibitors, NAD⁺ pathway modulators, fatty acid oxidation modulators, nutrient stress models, and recovery controls.
Molecular Probe, Biosensor & Assay Development
- Design fluorescent and luminescent probes based on rhodamine, cyanine, coumarin, BODIPY, naphthalimide, quinoline, lanthanide complexes, AIEgen scaffolds, or other signal platforms.
- Develop genetically encoded biosensor workflows for ATP/ADP, NADH/NAD⁺, redox state, or metabolic activity monitoring.
- Introduce mitochondrial targeting groups, solubility-enhancing units, ratiometric signal modules, time-resolved luminescent elements, enzyme-coupled assay components, or MS-compatible labeling groups.
- Optimize cellular uptake, expression conditions, response kinetics, signal-to-background ratio, dynamic range, photostability, water compatibility, and biological compatibility.
- Support assay format development for live cells, cell lysates, tissue extracts, organoids, whole blood, plasma, serum, and high-throughput screening plates.
Photophysical, Biochemical & Analytical Characterization
- Measure absorption spectra, emission spectra, excitation/emission maxima, Stokes shift, fluorescence intensity, luminescence intensity, luminescence lifetime, quantum yield, and signal stability.
- Evaluate response kinetics, linear range, detection limit, assay window, reproducibility, reversibility, and signal-to-background ratio.
- Test selectivity toward ATP, ADP, AMP, NADH, NAD⁺, NADPH, NADP⁺, glucose-related metabolites, lactate, pyruvate, fatty acid intermediates, TCA cycle metabolites, inorganic phosphate, and related cofactors.
- Assess pH stability, buffer compatibility, serum tolerance, solvent tolerance, storage stability, protein interference, matrix effects, and plate-reader compatibility.
- Characterize two-photon performance, NIR imaging behavior, high-content imaging suitability, MS fragmentation behavior, isotope incorporation accuracy, or multiplexed quantification performance when required.
Biological Validation & Imaging Assay Development
- Validate cell permeability, intracellular retention, mitochondrial localization, subcellular distribution, biosensor expression, and co-localization with organelle markers.
- Optimize staining concentration, biosensor transfection or stable expression, sample extraction, incubation time, plate format, imaging settings, and readout timing.
- Test probe or assay response in metabolic perturbation models, including ETC inhibition, glycolysis modulation, ATP synthase inhibition, NAMPT inhibition, hypoxia/reoxygenation, nutrient deprivation, fatty acid oxidation modulation, and drug-induced energy stress.
- Develop workflows for fluorescence microscopy, confocal imaging, two-photon microscopy, luminescence readers, fluorescence plate readers, flow cytometry, high-content imaging, LC-MS/MS, isotope tracing, organoid imaging, and selected animal model platforms.
- Establish quantitative analysis methods, including fluorescence ratio calculation, luminescence intensity analysis, standard curve generation, ATP/ADP ratio calculation, NADH/NAD⁺ ratio calculation, metabolite normalization, dose-response curves, IC₅₀ determination, and time-course monitoring.
Supported Sample Types and Models
- Cancer cell lines, tumor spheroids, organoids, and tumor metabolism models
- Mitochondrial dysfunction, oxidative phosphorylation, glycolysis, and nutrient stress models
- Drug-treated, chemotherapy-treated, metabolic inhibitor-treated, hypoxia/reoxygenation-treated, or nanomaterial-treated cells
- Hepatocytes, liver injury models, fatty liver models, and drug metabolism models
- Kidney organoids, renal proximal tubular models, and nephrotoxicity systems
- Cardiomyocyte and cardiotoxicity models, including H9C2 cells, primary cardiomyocytes, and iPSC-derived cardiomyocytes
- Neuronal and neurodegenerative disease models, including PC12 cells, SH-SY5Y cells, primary neurons, and brain tissue models
- Skin fibroblasts, keratinocytes, UV/oxidative stress skin aging models, and cosmetic efficacy models
- Microbiome samples, bacterial cultures, host-microbe co-culture systems, and gut metabolism models
- Plasma, serum, whole blood, tissue extracts, cell lysates, isolated mitochondria, and selected biological fluids
- 96-well, 384-well, low-volume 384-well, 1536-well, automated imaging, and high-content screening formats
- Other customized biological or analytical models upon request
Application
Drug Metabolic Toxicity and Mitochondrial Function Monitoring
Energy metabolism probes can provide early warning readouts for drug-induced mitochondrial dysfunction and metabolic toxicity. Mitochondrial membrane potential probes, ATP/ADP reporters, NADH/NAD⁺ assays, ROS probes, and metabolite profiling workflows can be combined to evaluate how candidate drugs affect oxidative phosphorylation, ATP synthesis, respiratory chain activity, and cellular energy homeostasis.
This application supports mitochondrial toxicity scoring, early drug safety evaluation, anticancer drug mechanism studies, metabolic liability screening, IND-supporting preclinical research, and high-throughput compound prioritization.
Tumor Glucose Metabolism Imaging and Cancer Theranostics
Tumor cells often reprogram energy metabolism and increase glucose uptake to support proliferation, stress adaptation, and survival. Glucose transporter-targeted probes or glucose-analogue imaging strategies can be used to visualize tumor metabolic activity, quantify tumor-to-normal tissue signal differences, and evaluate treatment-induced metabolic changes.
This application supports tumor metabolic imaging, anti-cancer drug efficacy assessment, metabolic reprogramming research, fluorescence-guided cancer studies, and preclinical evaluation of tumor metabolism-targeted therapies.
Fatty Acid β-Oxidation Probe Development for Metabolic Disease Research
Fatty acid β-oxidation is a key mitochondrial process in lipid catabolism and energy production. Fluorescence-based FAO probes and isotope-based metabolic tracing tools can help monitor fatty acid utilization, mitochondrial lipid metabolism, and pathway-specific metabolic activity in adipocytes, hepatocytes, cancer cells, and metabolic disease models.
This application supports probe development for diabetes, obesity, fatty liver disease, PPAR-α pathway studies, CPT-1-related target validation, metabolic drug screening, and mechanistic studies of lipid-energy metabolism.
Multi-Parameter Energy Metabolism Profiling for Drug Discovery
Energy metabolism is rarely defined by a single marker. A robust evaluation platform may integrate ATP/ADP ratio, NADH/NAD⁺ ratio, mitochondrial membrane potential, ROS, glucose utilization, lactate production, oxygen consumption, and metabolite profiling. This integrated approach can provide a more complete metabolic fingerprint for drug discovery and disease mechanism research.
This application supports integrated metabolic fingerprinting, mechanism-of-action studies, drug toxicity evaluation, high-content screening, multi-omics integration, and preclinical pharmacology workflows.
Our Advantages
- Integrated probe and assay development: We combine fluorescent probe design, luminescent assay engineering, genetically encoded biosensor workflows, enzymatic cycling assay optimization, metabolite labeling, and biological validation to generate practical energy metabolism analysis tools.
- Mitochondria-focused metabolism expertise: Our platform supports probe development for oxidative phosphorylation, ATP generation, NADH/NAD⁺ redox balance, mitochondrial membrane potential, fatty acid oxidation, metabolic stress, and mitochondrial toxicity models.
- Flexible detection strategy: We support fluorescence imaging, NIR imaging, two-photon imaging, time-resolved luminescence, bioluminescence, enzymatic assays, microplate detection, high-content imaging, LC-MS/MS, and stable isotope tracing.
- Application-oriented assay optimization: Probe performance can be tailored for live-cell imaging, organoid models, tumor metabolism, drug toxicity evaluation, metabolic disease research, supplement testing, cosmetic efficacy studies, and high-throughput screening.
- Multi-parameter mitochondrial profiling: Energy metabolism probe assays can be integrated with ROS, membrane potential, calcium, apoptosis, cell viability, oxygen consumption, glycolysis, ATP/ADP ratio, NADH/NAD⁺ ratio, and metabolite profiling to build a complete mitochondrial functional profile.
Contact Us
Develop sensitive, quantitative, and application-specific energy metabolism probes with Protheragen's Energy Metabolism Probe Development Service. Contact us with your target analyte, biological model, preferred detection platform, sample type, throughput requirement, mitochondrial localization need, and research objective. Our team will recommend a tailored probe or assay development strategy for mitochondrial metabolism analysis, drug metabolic toxicity evaluation, cancer metabolism research, metabolic disease models, organoid-based testing, and translational metabolic profiling.
References
1. Liu, H., Wang, S., Wang, J., et al. Energy metabolism in health and diseases. Signal Transduction and Targeted Therapy, 2025.
2. Tantama, M., Martínez-François, J. R., Mongeon, R., Yellen, G. Imaging energy status in live cells with a fluorescent biosensor of the intracellular ATP-to-ADP ratio. Nature Communications, 2013.
